Semaglutide weight loss injections are typically recommended for adults with a BMI (body mass index) of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, or obesity health risks
Incomplete Dissolution: Particulates indicate undissolved or aggregated peptide
Their website lists compounded GLP-1 (semaglutide-based), compounded GLP/GIP (tirzepatide-based), and brand-name Zepbound (FDA-approved tirzepatide)
www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
It is typically prescribed for individuals with a BMI of 30 or higher or for those with a BMI of 27 or above who also have obesity-related conditions like type 2 diabetes or hypertension
Heres the reality obesity is complex and there is no universal solution